Hazardous Risks
Clinical Trials: Risks
An Experimental Medical Atrocity Approved by Officials of the Indian Government
“Human beings are being treated like animals” R.M. Lodha, former Chief Justice of the Supreme Court of India An opinion article in The Sunday Guardian by Jacob Puliyel, MD, focuses on the plan to conduct unethical medical experiments in which human beings are deliberately infected with infectious diseases in order to develop possible vaccines. These…
Read MoreN.I.H. Seeks OK to Fund Human-Animal Stem Cell Experiments
Beware the month of August – when Congress and many citizens are vacationing! Government bureaucrats favor August to issue announcements about radical medical research policy changes, for which taxpayer money is sought. They do so, to avoid public controversy about public funding of radical experimentation…
Read MoreA Recent Deadly Drug Experiment – BIA 10-2474 – Rennes, France
Stakeholders in the Medical research enterprise, in the European Union and in the U.S., claim that clinical trials conducted on human subjects adhere to strict safety standards. “One of the things that sets clinical trials apart from other scientific experiments is the obligation for care. Investigators undertaking them have obligations to ensure that patients enrolled…
Read MoreAnti-AIDS pill, vaginal gel unsuitable for Africa: study
A scientific study that tested three different retreoviral drugs and vaginal gel in more than 5,000 HIV-negative women in Uganda, South Africa and Zimbabwe, FAILED to demonstrate the drugs’ effectiveness in preventing HIV.
Read MoreWomen’s Breasts Riddled With Metal by Mistake in a Study
About 30 women who participated in a clinical trial have been left hundreds of particles of potentially hazardous metal in their breast by a faulty disk made of tungsten and silicone that was used to shield against radiation exposure.
Read MoreRecent developments in gene transfer research: risk and ethics
Recent developments in gene transfer research: risk and ethics Mon, 10 Jan 2005 An analysis by Dr. Jonathan Kimmelman, in the British Medical Journal provides an illuminating, clearly articulated discussion about the ethical dilemmas that challenge gene transfer experiments – essentially a kind of human genetic engineering involving somatic cells, in which a genetically engineered…
Read MoreBad Medicine – Editorial – Guardian UK
Bad Medicine – Editorial – Guardian UK Sat, 12 Jun 2004 New York State Attorney General, Eliot Spitzer, is being recognized as a hero on both sides of the Atlantic. That’s because, unlike FDA officials, he knows how to use a “smoking gun” to affect change in corporate practices to protect the public health! An…
Read MoreCancer Trials: 60% to 70% of subjects are children – WSJ
July 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Wall Street Journal reports that there is a shortage of people volunteering to test experimental cancer drugs. “Overall, only 3% to 4% of cancer patients participate in trials. Most of those participants are children; about 60% to 70%…
Read MoreAnother Child Devloped Cancer: SCID Trials Suspended – ABC
Another Child Devloped Cancer: SCID Trials Suspended – ABC Tue, 14 Jan 2003 ABC News reports that the FDA suspended 30 gene therapy trials after a second child developed leukemia. So far, two boys who had undergone the experimental gene therapy treatment for immunodeficiency, “bubble boy disease” — or SCID–developed leukemia. “In gene therapy, a…
Read MoreBBC News: Key Data ‘Missing” in Catastrophic TGN1412 Drug Trial
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do."
Read MoreUK Chanel 4 Investigates: The Drug Trial That Went Wrong_Critique NEJM Editorial
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm It airs momorrow.
Read MoreVolunteers at Risk_Editorial, NEJM Justifies Catastrophic TGN1412 Experiment
"As long as we continue to manipulate biology in new ways, we probably cannot prevent all such events from occurring. We must do what we can to minimize risk, but the future health of the world population demands that we not let adverse events put an end to medical progress."
Read More